Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%

NCT01607671 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to recruit participants from recruiting sites.

Conditions

Optic Neuropathy, Ischemic
Anterior Ischemic Optic Neuropathy
Ischemic Optic Neuropathy
Optic Neuropathy, Anterior Ischemic

Interventions

DRUG: Timolol maleate

Sponsor

Fraser Health